Summary
This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
Conditions
Pediatric Low-grade Gliomas
Recruitment Status
Recruiting
Detailed Description
The purpose of the study is to develop new technologies for MRI systems. The new technologies should improve MRI capabilities in terms of how sensitive, specific, and efficient they are. The overall goal is to get better measurements of the brain tumor tissue(s). In this research study, the investigators want to learn more about investigational software and about techniques to process MR images. The testing of investigational software will allow the investigators to improve the image quality. As part of the testing process, the investigators will collect more MR images of the brain, and improve current image reconstruction methods. This will allow a more precise analysis of MR images and potentially better assessment of the brain tumor tissue volume.
Eligibility Criteria
Inclusion Criteria:
Infants, children and adults who have been diagnosed with Low Grade Glioma
Healthy volunteers - Children from age 0 to adults with no upper age limit or;
Diagnosed with LGG and being treated at DFCI;
Exclusion Criteria:
Electrical implants such as cardiac pacemakers or perfusion pumps;
Ferromagnetic implants such as aneurysm clips, surgical clips, prosthesis, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants;
Ferromagnetic objects such as jewelry or metal clips;
Women of childbearing age who are seeking to become pregnant, who are breastfeeding, or who suspect they may be pregnant;
Pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions;
Any greater than normal potential for cardiac arrest
Intervention
Intervention Type
Intervention Name
Other
Wave-CAIPI
Phase
Not Applicable
Gender
All
Min Age
0 Years
Max Age
N/A
Download Date
June 15, 2023
Principal Investigator
Ellen Grant
Primary Contact Information
For more information on this trial, visit clinicaltrials.gov.
Contact
For more information and to contact the study team: